Skip to main content

Portal Hypertension; Definition, Etiology and Management!

 PORTAL HYPERTENSION

Definition:

"Portal Hyperension is present when the hepatic venous pressure gradient exceeds 10mmHg and risk of variceal bleeding increases beyond a gradient of 12mmHg."



Classification: According to The Site of Action:

1. Pre-Hepatic, Pre-Sinusoidal:

    Caused by;

  •          Portal vein thrombosis due to sepsis
  •          Abdominal trauma including surgery.


2. Intra-hepatic pre-sinusoidal:

   Caused by; 

  •         Schistosomiasis
  •         Congenital hepatic fibrosis
  •         Drugs
  •         Sarcoidosis


3. Sinusoidal:

    Caused by; 

  •         Cirrhosis
  •         Polycystic liver disease
  •        Nodular regenerative hyperplasia
  •        Metastatic malignant disease


4. Intrahepatic Post-sinusoidal:

    Caused by; 

  •       Veno-occlusive disease


5. Post-hepatic post-sinusoidal:

  Caused by;

  •       Budd-Chiari syndrome


Etiology:

  1. Cirrhosis
  2. Schistosomiasis
  3. Portal vein thrombosis
  4. Drugs
  5. Fibrosis


Clinical Features:

  1. Variceal bleeding
  2. Congestive gastropathy
  3. Renal failure
  4. Iron deficiency anemia
  5. Hepatic encephalopathy
  6. Splenomegaly


Pathophysiology:

  • Increased portal vascular resistance leads to gradual reduction in flow of portal blood to liver and simultaneously to the development of collateral vessels, allowing portal blood to bypass liver and enter systemic circulation directly.
  • Poly systemic shunting occurs, particularly in the GIT and especially in the distal esophagus, stomach and rectum, in the anterior abdominal wall and in the renal, lumbar, ovarian and testicular vasculature.



Investigations:

  1. Portal venous Pressure is measured: by using a balloon catheter inserted using a trans jugular route.
  2. Endoscopy
  3. Ultrasonography
  4. CT scan
  5. MRI


Management of Bleeding:

1. IV Fluids: To replace the extracellular volume.

2. Vasopressor: To reduce the portal pressure, acute bleeding and risk of early bleeding.

3. Prophylactic Antibiotics (Cephalosporins IV): To reduce incidence of spontaneous bacterial peritonitis.

4. Emergency Endoscopy: To confirm variceal rather than ulcer bleeding.

5. PPI: To prevent peptic ulcer.

6. Variceal Band Ligation: To stop bleeding.

7. Phosphate Enema/ Lactulose: To prevent hepatic encephalopathy.


Management of Acute Bleeding From Esophageal Varices:

  1. If suspected variceal hemorrhage.
  2. Start IV Terlipressin (Vasopressor) and Antibiotics prophylaxis.
  3. Urgent Upper GI Endoscopy:
  4. If Varices present, go for, Endoscopic Therapy. (If no varices present; stop Terlipressin.)
  5. Is there hemostasis. If yes; continue Terlipressin to 72hr. Introduce Beta-blocker as secondary prophylaxis. Enter the patient to endoscopic banding program to obliterate varices. (If no Hemostats; Further endoscopic therapy or Ballon Tamporate and Emergency Trans jugular Intrahepatic Portosystemic Stent Shunt (TIPSS)).



Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Clinical Presentation and Diagnosis!

 CLINICAL PRESENTATION AND DIAGNOSIS OF DM 2. SCREENING American Diabetes Association (ADA) recommends routine screening for T2 DM every 3 years in all adults starting at 45 years of age. Testing of T2 DM should be considered in any adult, regardless of their age, who have a BMI greater than or equal to 25kg/m2. The ADA does not currently recommend widespread screening for T1 DM because of the relatively low incidence in the general population, although measurement of Islet antibodies may be appropriate for high-risk individuals. 3.GESTATIONAL DIABETES: "Gestational diabetes is the glucose intolerance in women during pregnancy". All pregnant women who have risk factors for T2 DM should be screened for undiagnosed T2 DM at their first prenatal visit using standard diagnostic criteria.  Any women found to have diabetes in the early point at pregnancy is considered to have T2 DM or GDM. All other pregnant women, not currently known to have DM should be screened for GDM with a 75...
Post a Comment
Read more

Hospital Acquired Pneumonia- Definition, Predisposing Factors, Clinical Features and Management!

 HOSPITAL ACQUIRED PNEUMONIA Definition: "HAP refers to a new episode of pneumonia occurring at least 2 days after the administration to hospital. It is the most common Hospital Acquired Infection (HAI) and leading cause of HAI-associated death". Predisposing factors: Aspiration of nasopharyngeal secretion Bacteria introduced into the lower GIT. Bacteriaemia Old age Mode of Spread:  Droplet infection Infecting agent: Bacteria: S.pneumonia , S.aureus , H.influenza Virus: Adenovirus, Corona virus, Herpes Simplex Clinical Features: Purulent sputum New radiological infiltrates Temperature > 38 degree Celsius Leukocytosis Investigations: Chest Pain:  to confirm the diagnosis and exclude complication. Pulse Oximetry : to monitor response to oxygen therapy, if SaO2 < 93% features of sever pneumonia, identify ventilatory failure or acidosis. Cell count:  ESR, Neutrophil leukocytosis Microbiological studies:  for severe CAP and those that do not respond to ...
Post a Comment
Read more

Management of H.pylori and NSAID-associated ulcers Eradication!

MANAGEMENT FOR H.PYLORI ERADICATION It is known that H.pylori infection is associated with over 90% of duodenal ulcers and 80% of Gastric Ulcers. Antibiotics alone or acid-suppressing agents alone, do not eradicate H.pylori . Both therapies act synergistically as growth of the organism occurs at elevated pH and antibiotics efficacy is enhanced during growth. Additionally, increasing intragastric pH may enhance antibiotic absorption. High eradication rates are achieved by a short course of Triple Therapy consisting of:            1 .PPI                                         2. Clarithromycin                         3. Amoxicillin/Metronidazole          in a twice recommended simultaneous regimen. First-Line Therapy :  European Guidelines recommended 1 we...
Post a Comment
Read more